Alveolar dead-space response to activated protein c in acute respiratory distress syndrome

Respiratory Care

Volumn 55, Issue 5, 2010, Pages 617-622

  Kallet, Richard H ^a   Jasmer, Robert M ^a   Pittet, Jean Francois ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Activated protein c; Acute respiratory distress syndrome; Alveolar dead space; Ards; Lung protective ventilation; Physiologic dead space; Severe sepsis; Single breath test for carbon dioxide; Volumetric capnog raphy

Indexed keywords

ADRENALIN; AMPHOTERICIN B LIPID COMPLEX; CEFTRIAXONE; COTRIMOXAZOLE; DOPAMINE; DROTRECOGIN; FENTANYL; HEPARIN; MIDAZOLAM; NORADRENALIN; PHENYLEPHRINE; VANCOMYCIN; VECURONIUM; FIBRINOLYTIC AGENT; PROTEIN C;

ACUTE KIDNEY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGITATION; AMBIENT AIR; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTERIAL PH; ARTICLE; BLEEDING; BLOOD ANALYSIS; BLOOD CARBON DIOXIDE TENSION; BLOOD CULTURE; BLOOD PRESSURE; BREATHING; BREATHING RATE; CANDIDEMIA; CAPNOGRAPHY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS HEMOFILTRATION; CONTINUOUS INFUSION; CORE TEMPERATURE; DEATH; DEEP VEIN THROMBOSIS; DRUG WITHDRAWAL; DYSPNEA; FECES; GASTROINTESTINAL HEMORRHAGE; HEART RATE; HEMATOCHEZIA; HEMATOCRIT; HUMAN; HUMIDIFIER; INFERIOR CAVA VEIN OBSTRUCTION; INSPIRED OXYGEN FRACTION; INTUBATION; KIDNEY VEIN THROMBOSIS; LUNG COMPLIANCE; LUNG DEAD SPACE; LUNG FUNCTION; LUNG INFILTRATE; LUNG LAVAGE; LUNG PERFUSION; MALE; MEAN ARTERIAL PRESSURE; MENTAL HEALTH; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NECROTIZING PNEUMONIA; OXYGEN SATURATION; OXYGENATION; PLEURA EFFUSION; PNEUMONIA; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; PULSE OXIMETRY; SENSOR; SEPTIC SHOCK; SIDE EFFECT; THORAX RADIOGRAPHY; TIDAL VOLUME; TREATMENT OUTCOME; VOMITING; DOSE RESPONSE; DRUG EFFECT; FATALITY; FOLLOW UP; LUNG ALVEOLUS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; CAPNOGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; FATAL OUTCOME; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MALE; PROTEIN C; PULMONARY ALVEOLI; RESPIRATORY DEAD SPACE; RESPIRATORY DISTRESS SYNDROME, ADULT; TIDAL VOLUME;

EID: 77954583579     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342(18):1334-1349.
2. Kallet RH, Alonso JA, Pittet JF, Matthay MA. Prognostic value of the pulmonary dead-space fraction during the first six days of acute respiratory distress syndrome. Respir Care 2004;49(9):1008-1014.
3. Nuckton T, Alonso J, Kallet R, Daniel B, Pittet JP, Eisner M, Mat-thay MA. Early elevation in dead-space ventilation is associated with mortality risk in patients with acute respiratory distress syndrome. N Engl J Med 2002;346(17):1281-1286.
4. Esmon CT. TheproteinCanticoagulantpathway.ArteriosclerThromb 1992;12(1):35-45.
5. Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, Takatsuki K. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 1996;87(2):642-647.
6. Ware LB, Matthay MA, Parsons PE, Thompson PT, Januzzi JL, Eisner MD; National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med 2007;35(8):1821-1828.
7. Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, et al. Septic shock, multiple organ failure, and disseminated intra-vascular coagulation: compare patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992;101(3):816-823.
8. Bernard GR, Vicent JL, Laterre PF, LaRosa SP, Dhainult JF, Lopez-Rodriguez A, et al; PROWESS Study Group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344(10):699-709.
9. Liu KD, Levitt J, Zhuo H, Kallet RH, Brady S, Steingrub J, et al. Randomized clinical trial of activated protein C for the treatment of acute lung injury. Am J Respir Crit Care Med 2008;178(6):618-623.
10. NHLBI Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute respiratory distress syndrome. N Engl J Med 2000; 342(18): 1301-1308.
11. Kallet RH, Daniel BM, Garcia O, Matthay MA. Accuracy of physiologic dead-space measurements in patients with acute respiratory distress syndrome using volumetric capnography: comparison with the metabolic monitor method. Respir Care 2005;50(4):462-467.
12. Enghoff H. Volumen inefficax: bemerkungen zur frage des schädli-chen raumes. Upsala Lakareforen Forh 1938;44:191-218. Article in German.
13. Fletcher R, Jonson B, Cumming G, Brew J. The concept of dead-space with special reference to the single breath test for carbon dioxide. Brit J Anaesth 1981;53(1):77-88.
14. Zapol WM, Kobayashi K, Snider MT, Greene R, Laver MB. Vascular obstruction causes pulmonary hypertension in severe acute respiratory failure. Chest 1977;71(2 Suppl):306-307.
15. Greene R, Zapol WM, Snider MT, Reid L, Snow R, O'Connell RS, Novelline RA. Early bedside detection of pulmonary vascular occlusion during acute respiratory failure. Am Rev Respir Dis 1981; 124(5):593-601.
16. Zapol WM, Jones R. Vascular components of ARDS: clinical pulmonary, hemodynamics and morphology. Am Rev Respir Dis 1987; 136(2):471-474.
17. Tomashefski JF, Davies P, Boggis C, Greene R, Zapol WM, Reid LM. The pulmonary vascular lesions of adult respiratory distress syndrome. Am J Pathol 1983;112(1):112-126.
18. Vieillard-Baron A. Assessment of right ventricular function. Curr Opin Crit Care 2009;15(3):254-260.
19. Gattinoni L, Pelosi P, Suter PM, Pedoto A, Vercesi P, Lissoni A. Acute respiratory distress syndrome caused by pulmonary and ex-trapulmonary disease: different syndromes? Am J Respir Crit Care Med 1998;158(1):3-11.
20. Ahmed SN, Syed FM, Porembka DT. Echocardiographic evaluation of hemodynamic parameters. Crit Care Med 2007;35(8):S323-S329.
21. Suter PM, Fairley HB, Isenberg MD. Optimum end-expiratory airway pressure in patients with acute pulmonary failure. N Engl J Med 1975;292(6):284-289.
22. Kuwabara S, Duncalf D. Effect of anatomic shunt on physiologic deadspace-to-tidal volume ratio: a new equation. Anesthesiology 1969;31(6):575-577.
23. Hough CL, Kallet RH, Ranieri VM, Rubenfeld GD, Luce JM, Hudson LD. Intrinsic positive end-expiratory pressure in Acute Respiratory Distress Syndrome (ARDS) Network subjects. Crit Care Med 2005;33(3):527-532.
24. Dixon B, Campbell DJ, Santamaria JD. Elevated pulmonary dead space and coagulation abnormalities suggesting lung microvascular thrombosis in patients undergoing cardiac surgery. Intensive Care Med 2008;34(7):1216-1223.
25. Greene R, Lind S, Jantsch H, Wilson R, Lynch K, Jones R, et al. Pulmonary vascular obstruction in severe ARDS: angiopgrahic alterations after fibrinolytic therapy. AJR Am J Roentgenol 1987; 148(3):501-508.
26. Kiiski R, Takala J, Kari A, Milic-Emili J. Effect of tidal volume on gas exchange and oxygen transport in the adult respiratory distress syndrome. Am Rev Respir Dis 1992;146(5 Pt 1):1131-1135.
27. Anderson JT. Embolism. In: Gravenstein JS, Jaffee MB, Paulus DA, editors. Capnography: clinical aspects. Cambridge: Cambridge University Press; 2004:187-198.